Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Van Dijck

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Sexually Transmitted Infections|January 5, 2023
No evidence of reduced cephalosporin susceptibility of circulating strains of <i>Neisseria gonorrhoeae</i> in the Netherlands despite nearly a decade of recommending ceftriaxone monotherapyChristophe Van Dijck, Chris Kenyon
Sexually Transmitted Diseases|December 20, 2019
Could Intensive Screening for Gonorrhea/Chlamydia in Preexposure Prophylaxis Cohorts Select for Resistance? Historical Lessons From a Mass Treatment Campaign in GreenlandChris Kenyon, Jolein Laumen, Christophe Van Dijck
International Journal of STD & AIDS|January 4, 2022
Recent insights suggest the need for the STI field to embrace a more eco-social conceptual framework: A viewpointChris Kenyon, Thibaut Vanbaelen, Christophe Van Dijck
Current Opinion in Infectious Diseases|December 3, 2019
Facing increased sexually transmitted infection incidence in HIV preexposure prophylaxis cohorts: what are the underlying determinants and what can be done?Chris Kenyon, Christophe Van Dijck, Eric Florence
Acta Clinica Belgica|April 15, 2016
A 54-year-old Philippine sailor with fever and jaundiceChristophe Van Dijck, Marjan Van Esbroeck, Robert Rutsaert
Bulletin of the World Health Organization|April 27, 2018
Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic reviewChristophe Van Dijck, Erika Vlieghe, Janneke Arnoldine Cox
Open Forum Infectious Diseases|June 26, 2025
Switching From Dual to Monotherapy for Gonorrhea is Associated With a Halving of Gonococcal Resistance to Azithromycin-A Modelling Study of MSM in BelgiumAchilleas Tsoumanis, Christophe Van Dijck, Niel Hens, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 17, 2021
Is There a Resistance Threshold for Macrolide Consumption? Positive Evidence from an Ecological Analysis of Resistance Data from <i>Streptococcus pneumoniae</i>, <i>Treponema pallidum,</i> and <i>Mycoplasma genitalium</i>Chris Kenyon, Sheeba S Manoharan-Basil, Christophe Van Dijck
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2022
The Roles of Unrecognized Mpox Cases, Contact Isolation and Vaccination in Determining Epidemic Size in Belgium: A Modeling StudyChristophe Van Dijck, Niel Hens, Chris Kenyon, et al.
Antimicrobial Resistance and Infection Control|July 2, 2020
Gonococcal resistance can be viewed productively as part of a syndemic of antimicrobial resistance: an ecological analysis of 30 European countriesChris Kenyon, Sheeba S Manoharan-Basil, Christophe Van Dijck
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Sexually Transmitted Infections|January 5, 2023
No evidence of reduced cephalosporin susceptibility of circulating strains of <i>Neisseria gonorrhoeae</i> in the Netherlands despite nearly a decade of recommending ceftriaxone monotherapyChristophe Van Dijck, Chris Kenyon
Sexually Transmitted Diseases|December 20, 2019
Could Intensive Screening for Gonorrhea/Chlamydia in Preexposure Prophylaxis Cohorts Select for Resistance? Historical Lessons From a Mass Treatment Campaign in GreenlandChris Kenyon, Jolein Laumen, Christophe Van Dijck
International Journal of STD & AIDS|January 4, 2022
Recent insights suggest the need for the STI field to embrace a more eco-social conceptual framework: A viewpointChris Kenyon, Thibaut Vanbaelen, Christophe Van Dijck
Current Opinion in Infectious Diseases|December 3, 2019
Facing increased sexually transmitted infection incidence in HIV preexposure prophylaxis cohorts: what are the underlying determinants and what can be done?Chris Kenyon, Christophe Van Dijck, Eric Florence
Acta Clinica Belgica|April 15, 2016
A 54-year-old Philippine sailor with fever and jaundiceChristophe Van Dijck, Marjan Van Esbroeck, Robert Rutsaert
Bulletin of the World Health Organization|April 27, 2018
Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic reviewChristophe Van Dijck, Erika Vlieghe, Janneke Arnoldine Cox
Open Forum Infectious Diseases|June 26, 2025
Switching From Dual to Monotherapy for Gonorrhea is Associated With a Halving of Gonococcal Resistance to Azithromycin-A Modelling Study of MSM in BelgiumAchilleas Tsoumanis, Christophe Van Dijck, Niel Hens, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 17, 2021
Is There a Resistance Threshold for Macrolide Consumption? Positive Evidence from an Ecological Analysis of Resistance Data from <i>Streptococcus pneumoniae</i>, <i>Treponema pallidum,</i> and <i>Mycoplasma genitalium</i>Chris Kenyon, Sheeba S Manoharan-Basil, Christophe Van Dijck
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2022
The Roles of Unrecognized Mpox Cases, Contact Isolation and Vaccination in Determining Epidemic Size in Belgium: A Modeling StudyChristophe Van Dijck, Niel Hens, Chris Kenyon, et al.
Antimicrobial Resistance and Infection Control|July 2, 2020
Gonococcal resistance can be viewed productively as part of a syndemic of antimicrobial resistance: an ecological analysis of 30 European countriesChris Kenyon, Sheeba S Manoharan-Basil, Christophe Van Dijck
Pageof 8